Lipid-Lowering Drug Effects Beyond the Cardiovascular System: Relevance for Neuropsychiatric Disorders

Overview

Journal Int J Neuropsychopharmacol

Publisher Oxford University Press

Specialty Psychiatry

Date 2018 Oct 18

PMID 30329063

Citations 7

Authors

Falk W Lohoff

Affiliations

Soon will be listed here.

Citing Articles

Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome.

Pihtili Tas N, Baykara R, Kamanli A, Gurbuz A, Cure E, Cumhur Cure M Arch Rheumatol. 2024; 39(3):375-383.

PMID: 39507838 PMC: 11537681. DOI: 10.46497/ArchRheumatol.2024.10462.

PCSK9 Inhibition Reduces Depressive like Behavior in CUMS-Exposed Rats: Highlights on HMGB1/RAGE/TLR4 Pathway, NLRP3 Inflammasome Complex and IDO-1.

Hendawy N, Salaheldin T, Abuelezz S J Neuroimmune Pharmacol. 2023; 18(1-2):195-207.

PMID: 36781714 PMC: 10485135. DOI: 10.1007/s11481-023-10060-3.

PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder.

Lee J, OConnell E, Pacher P, Lohoff F J Clin Med. 2021; 10(8).

PMID: 33919550 PMC: 8074019. DOI: 10.3390/jcm10081758.

Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.

Macchi C, Favero C, Ceresa A, Vigna L, Conti D, Pesatori A Cardiovasc Diabetol. 2020; 19(1):187.

PMID: 33143700 PMC: 7641831. DOI: 10.1186/s12933-020-01158-6.

Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder.

Rosoff D, Charlet K, Jung J, Lee J, Muench C, Luo A Alcohol. 2020; 86:93-101.

PMID: 32335269 PMC: 7486690. DOI: 10.1016/j.alcohol.2020.02.164.

References

Benn M, Nordestgaard B, Frikke-Schmidt R, Tybjaerg-Hansen A . Low LDL cholesterol, and genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study. BMJ. 2017; 357:j1648. PMC: 5421439. DOI: 10.1136/bmj.j1648. View

Ference B, Robinson J, Brook R, Catapano A, Chapman M, Neff D . Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. N Engl J Med. 2016; 375(22):2144-2153. DOI: 10.1056/NEJMoa1604304. View

Seidah N, Awan Z, Chretien M, Mbikay M . PCSK9: a key modulator of cardiovascular health. Circ Res. 2014; 114(6):1022-36. DOI: 10.1161/CIRCRESAHA.114.301621. View

Otte C, Gold S, Penninx B, Pariante C, Etkin A, Fava M . Major depressive disorder. Nat Rev Dis Primers. 2016; 2:16065. DOI: 10.1038/nrdp.2016.65. View

Do R, Willer C, Schmidt E, Sengupta S, Gao C, Peloso G . Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013; 45(11):1345-52. PMC: 3904346. DOI: 10.1038/ng.2795. View

Abifadel M, Varret M, Rabes J, Allard D, Ouguerram K, Devillers M . Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003; 34(2):154-6. DOI: 10.1038/ng1161. View

Dekkers K, van Iterson M, Slieker R, Moed M, Bonder M, van Galen M . Blood lipids influence DNA methylation in circulating cells. Genome Biol. 2016; 17(1):138. PMC: 4922056. DOI: 10.1186/s13059-016-1000-6. View

Rosenson R, Hegele R, Fazio S, Cannon C . The Evolving Future of PCSK9 Inhibitors. J Am Coll Cardiol. 2018; 72(3):314-329. DOI: 10.1016/j.jacc.2018.04.054. View

Golomb B, Tenkanen L, Alikoski T, Niskanen T, Manninen V, Huttunen M . Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol. 2002; 55(8):767-73. DOI: 10.1016/s0895-4356(02)00407-9. View

10.

Filippatos T, Christopoulou E, Elisaf M . Pleiotropic effects of proprotein convertase subtilisin/kexin type 9 inhibitors?. Curr Opin Lipidol. 2018; 29(4):333-339. DOI: 10.1097/MOL.0000000000000523. View

11.

Taher J, Farr S, Adeli K . Central nervous system regulation of hepatic lipid and lipoprotein metabolism. Curr Opin Lipidol. 2016; 28(1):32-38. DOI: 10.1097/MOL.0000000000000373. View

12.

Farnier M, Gaudet D, Valcheva V, Minini P, Miller K, Cariou B . Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials. Int J Cardiol. 2016; 223:750-757. DOI: 10.1016/j.ijcard.2016.08.273. View

13.

Dwivedi D, Grin P, Khan M, Prat A, Zhou J, Fox-Robichaud A . Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis. Shock. 2016; 46(6):672-680. DOI: 10.1097/SHK.0000000000000682. View

14.

Bruce K, Zsombok A, Eckel R . Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism. Front Endocrinol (Lausanne). 2017; 8:60. PMC: 5378716. DOI: 10.3389/fendo.2017.00060. View

15.

Bennett D, Holmes M . Mendelian randomisation in cardiovascular research: an introduction for clinicians. Heart. 2017; 103(18):1400-1407. PMC: 5574403. DOI: 10.1136/heartjnl-2016-310605. View

16.

Lotta L, Sharp S, Burgess S, Perry J, Stewart I, Willems S . Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. JAMA. 2016; 316(13):1383-1391. PMC: 5386134. DOI: 10.1001/jama.2016.14568. View

17.

Sarchiapone M, Roy A, Camardese G, De Risio S . Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord. 2000; 61(1-2):69-71. DOI: 10.1016/s0165-0327(99)00198-6. View

18.

Lohoff F, Sorcher J, Rosen A, Mauro K, Fanelli R, Momenan R . Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder. Mol Psychiatry. 2017; 23(9):1900-1910. PMC: 5832488. DOI: 10.1038/mp.2017.168. View

19.

Danesh J, Erqou S, Walker M, Thompson S, Tipping R, Ford C . The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69. DOI: 10.1007/s10654-007-9165-7. View

20.

Seidah N, Chretien M, Mbikay M . The ever-expanding saga of the proprotein convertases and their roles in body homeostasis: emphasis on novel proprotein convertase subtilisin kexin number 9 functions and regulation. Curr Opin Lipidol. 2018; 29(2):144-150. DOI: 10.1097/MOL.0000000000000484. View